ProShares Ultra Bloomberg Natural Gas

United States Natural Gas

GraniteShares 1.5x Short NVDA Daily ETF

Direxion Daily S&P Biotech Bull 3X ETF

MicroSectors Gold Miners 3X Leveraged ETN

Global X Uranium ETF

Direxion Dly S&P Oil&Gs Ex&Prd Bl 3X ETF

Direxion Daily Gold Miners Bull 3X ETF

Direxion Daily 20+ Yr Trsy Bull 3X ETF

ProShares UltraShort Bloomberg Natrl Gas

GraniteShares 1.5x Long Coinbase Daily ETF

Direxion Daily S&P Biotech Bear 3X ETF

GraniteShares 1.5x Long NVDA Daily ETF

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

United States Oil Fund

Direxion Daily 20+ Yr Trsy Bear 3X ETF

Volatility Shares Trust 2x Bitcoin Strategy ETF

Direxion Daily Gold Miners Bear 3X ETF

Easterly Government Properties Inc. Common Stock

AGM Group Holdings Inc. Class A Ordinary Shares

Petros Pharmaceuticals Inc. Common Stock

Pony AI Inc. American Depositary Shares

Portage Biotech Inc. Common Stock

Plug Power Inc. Common Stock

Leggett & Platt Incorporated Common Stock

Altisource Portfolio Solutions S.A. Common Stock

Noble Corporation plc A Ordinary Shares

NIO Inc. American depositary shares each  representing one Class A ordinary share

Spire Global Inc. Class A Common Stock

Ecopetrol S.A. American Depositary Shares

NXP Semiconductors N.V. Common Stock

Tiziana Life Sciences Ltd. Common Shares

MicroFinancial Inc.

TTEC Holdings Inc. Common Stock

PENN Entertainment Inc. Common Stock

Check-Cap Ltd. Ordinary Share

Bioventus Inc. Class A Common Stock

Canaan Inc. American Depositary Shares

Click here to get full coverage on Nerdio Manager for MSP 6.0 Brings Unified Microsoft 365 and AVD Management to the Forefront - ChannelE2E

Nerdio Manager for MSP 6.0 Brings Unified Microsoft 365 and AVD Management to the Forefront  ChannelE2E

Nerdio Manager for MSP 6.0 Brings Unified Microsoft 365 and AVD Management to the Forefront - ChannelE2E

Click here to get full coverage on How to set up and use Azure Virtual Desktop - TechTarget

How to set up and use Azure Virtual Desktop  TechTarget

How to set up and use Azure Virtual Desktop - TechTarget

Click here to get full coverage on (AVD) Investment Analysis - news.stocktradersdaily.com

(AVD) Investment Analysis  news.stocktradersdaily.com

(AVD) Investment Analysis - news.stocktradersdaily.com

Click here to get full coverage on Nivolumab and AVD the New Standard in Hodgkin Lymphoma - National Cancer Institute (.gov)

Nivolumab and AVD the New Standard in Hodgkin Lymphoma  National Cancer Institute (.gov)

Nivolumab and AVD the New Standard in Hodgkin Lymphoma - National Cancer Institute (.gov)

Click here to get full coverage on Nivolumab Plus AVD as Front-Line Therapy in Older Adults With Classical Hodgkin Lymphoma - The ASCO Post

Nivolumab Plus AVD as Front-Line Therapy in Older Adults With Classical Hodgkin Lymphoma  The ASCO Post

Nivolumab Plus AVD as Front-Line Therapy in Older Adults With Classical Hodgkin Lymphoma - The ASCO Post

Click here to get full coverage on From ABVD to Nivolumab-AVD: New Treatment Strategies in Hodgkin Lymphoma - Targeted Oncology

From ABVD to Nivolumab-AVD: New Treatment Strategies in Hodgkin Lymphoma  Targeted Oncology

From ABVD to Nivolumab-AVD: New Treatment Strategies in Hodgkin Lymphoma - Targeted Oncology

Click here to get full coverage on NYSE Issues Warning: American Vanguard Misses Critical Annual Report Deadline - Stock Titan

NYSE Issues Warning: American Vanguard Misses Critical Annual Report Deadline  Stock Titan

NYSE Issues Warning: American Vanguard Misses Critical Annual Report Deadline - Stock Titan

Click here to get full coverage on Nerdio Accelerates Microsoft 365 Management for Modern MSPs with Launch of Nerdio Manager for MSP 6.0 - Yahoo Finance

Nerdio Accelerates Microsoft 365 Management for Modern MSPs with Launch of Nerdio Manager for MSP 6.0  Yahoo Finance

Nerdio Accelerates Microsoft 365 Management for Modern MSPs with Launch of Nerdio Manager for MSP 6.0 - Yahoo Finance

Click here to get full coverage on Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma - The New England Journal of Medicine

Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma  The New England Journal of Medicine

Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma - The New England Journal of Medicine

Click here to get full coverage on Black screens still plague Windows 10 Azure Virtual Desktop users - theregister.com

Black screens still plague Windows 10 Azure Virtual Desktop users  theregister.com

Black screens still plague Windows 10 Azure Virtual Desktop users - theregister.com

Click here to get full coverage on Explore Findings With Nivolumab Plus AVD in Advanced-Stage Classic Hodgkin Lymphoma: With Alex F. Herrera, MD - OncLive

Explore Findings With Nivolumab Plus AVD in Advanced-Stage Classic Hodgkin Lymphoma: With Alex F. Herrera, MD  OncLive

Explore Findings With Nivolumab Plus AVD in Advanced-Stage Classic Hodgkin Lymphoma: With Alex F. Herrera, MD - OncLive

Click here to get full coverage on Nerdio Expands Beyond AVD to Full Microsoft 365 Management - Channel Futures

Nerdio Expands Beyond AVD to Full Microsoft 365 Management  Channel Futures

Nerdio Expands Beyond AVD to Full Microsoft 365 Management - Channel Futures

Click here to get full coverage on Azure Virtual Desktop: The Definitive Guide for IT Pros - Petri IT Knowledgebase

Azure Virtual Desktop: The Definitive Guide for IT Pros  Petri IT Knowledgebase

Azure Virtual Desktop: The Definitive Guide for IT Pros - Petri IT Knowledgebase

Click here to get full coverage on Nivolumab+AVD improves progression-free survival in advanced-stage Hodgkin lymphoma - 2 Minute Medicine

Nivolumab+AVD improves progression-free survival in advanced-stage Hodgkin lymphoma  2 Minute Medicine

Nivolumab+AVD improves progression-free survival in advanced-stage Hodgkin lymphoma - 2 Minute Medicine

Click here to get full coverage on Aviceda Therapeutics Completes Enrollment of Phase 2b SIGLEC Study Assessing the Safety and Efficacy of AVD-104 for Geographic Atrophy Secondary to AMD - Business Wire

Aviceda Therapeutics Completes Enrollment of Phase 2b SIGLEC Study Assessing the Safety and Efficacy of AVD-104 for Geographic Atrophy Secondary to AMD  Business Wire

Aviceda Therapeutics Completes Enrollment of Phase 2b SIGLEC Study Assessing the Safety and Efficacy of AVD-104 for Geographic Atrophy Secondary to AMD - Business Wire

Click here to get full coverage on American Vanguard Corporation's (NYSE:AVD) recent 11% pullback adds to one-year year losses, institutional owners may take drastic measures - Yahoo Finance

American Vanguard Corporation's (NYSE:AVD) recent 11% pullback adds to one-year year losses, institutional owners may take drastic measures  Yahoo Finance

American Vanguard Corporation's (NYSE:AVD) recent 11% pullback adds to one-year year losses, institutional owners may take drastic measures - Yahoo Finance

Click here to get full coverage on Comparing VMware Horizon vs. Azure Virtual Desktop - TechTarget

Comparing VMware Horizon vs. Azure Virtual Desktop  TechTarget

Comparing VMware Horizon vs. Azure Virtual Desktop - TechTarget

Click here to get full coverage on American Vanguard Targets Double EBITDA Margins After Strategic Repositioning - Stock Titan

American Vanguard Targets Double EBITDA Margins After Strategic Repositioning  Stock Titan

American Vanguard Targets Double EBITDA Margins After Strategic Repositioning - Stock Titan

Click here to get full coverage on Dr Herrera on Nivolumab vs Brentuximab Vedotin Plus AVD in Hodgkin Lymphoma - OncLive

Dr Herrera on Nivolumab vs Brentuximab Vedotin Plus AVD in Hodgkin Lymphoma  OncLive

Dr Herrera on Nivolumab vs Brentuximab Vedotin Plus AVD in Hodgkin Lymphoma - OncLive

Click here to get full coverage on Enrollment complete in phase 2b study of AVD-104 for geographic atrophy secondary to AMD - Healio

Enrollment complete in phase 2b study of AVD-104 for geographic atrophy secondary to AMD  Healio

Enrollment complete in phase 2b study of AVD-104 for geographic atrophy secondary to AMD - Healio

Click here to get full coverage on NICE recommends brentuximab vedotin plus AVD for Hodgkin lymphoma - PharmaTimes

NICE recommends brentuximab vedotin plus AVD for Hodgkin lymphoma  PharmaTimes

NICE recommends brentuximab vedotin plus AVD for Hodgkin lymphoma - PharmaTimes

Click here to get full coverage on Aviceda Therapeutics Raises Upsized $207.5 Million in Series C Financing Round to Advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials - Business Wire

Aviceda Therapeutics Raises Upsized $207.5 Million in Series C Financing Round to Advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials  Business Wire

Aviceda Therapeutics Raises Upsized $207.5 Million in Series C Financing Round to Advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials - Business Wire

Click here to get full coverage on Nerdio unveils unified Microsoft 365 & AVD solution for MSPs - ChannelLife Australia

Nerdio unveils unified Microsoft 365 & AVD solution for MSPs  ChannelLife Australia

Nerdio unveils unified Microsoft 365 & AVD solution for MSPs - ChannelLife Australia

Click here to get full coverage on Investors Still Aren't Entirely Convinced By American Vanguard Corporation's (NYSE:AVD) Revenues Despite 33% Price Jump - simplywall.st

Investors Still Aren't Entirely Convinced By American Vanguard Corporation's (NYSE:AVD) Revenues Despite 33% Price Jump  simplywall.st

Investors Still Aren't Entirely Convinced By American Vanguard Corporation's (NYSE:AVD) Revenues Despite 33% Price Jump - simplywall.st

Click here to get full coverage on Nivolumab-Chemotherapy Combo Boosts PFS in cHL, Poised for Standard Use - Targeted Oncology

Nivolumab-Chemotherapy Combo Boosts PFS in cHL, Poised for Standard Use  Targeted Oncology

Nivolumab-Chemotherapy Combo Boosts PFS in cHL, Poised for Standard Use - Targeted Oncology

Click here to get full coverage on After losing 48% in the past year, American Vanguard Corporation (NYSE:AVD) institutional owners must be relieved by the recent gain - simplywall.st

After losing 48% in the past year, American Vanguard Corporation (NYSE:AVD) institutional owners must be relieved by the recent gain  simplywall.st

After losing 48% in the past year, American Vanguard Corporation (NYSE:AVD) institutional owners must be relieved by the recent gain - simplywall.st

Click here to get full coverage on Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma | Journal of Clinical Oncology - ASCO Publications

Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma | Journal of Clinical Oncology  ASCO Publications

Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma | Journal of Clinical Oncology - ASCO Publications

Click here to get full coverage on Data for Nivolumab Plus AVD Could Help Harmonize Treatment of Older and Younger Advanced-Stage Hodgkin Lymphoma - OncLive

Data for Nivolumab Plus AVD Could Help Harmonize Treatment of Older and Younger Advanced-Stage Hodgkin Lymphoma  OncLive

Data for Nivolumab Plus AVD Could Help Harmonize Treatment of Older and Younger Advanced-Stage Hodgkin Lymphoma - OncLive

Click here to get full coverage on Analysts Have Been Trimming Their American Vanguard Corporation (NYSE:AVD) Price Target After Its Latest Report - simplywall.st

Analysts Have Been Trimming Their American Vanguard Corporation (NYSE:AVD) Price Target After Its Latest Report  simplywall.st

Analysts Have Been Trimming Their American Vanguard Corporation (NYSE:AVD) Price Target After Its Latest Report - simplywall.st

Click here to get full coverage on The past five years for American Vanguard (NYSE:AVD) investors has not been profitable - Yahoo Finance

The past five years for American Vanguard (NYSE:AVD) investors has not been profitable  Yahoo Finance

The past five years for American Vanguard (NYSE:AVD) investors has not been profitable - Yahoo Finance

Click here to get full coverage on Jeito Capital announces significant participation in upsized $207.5 million Series C financing in Aviceda Therapeutics to advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials - GlobeNewswire

Jeito Capital announces significant participation in upsized $207.5 million Series C financing in Aviceda Therapeutics to advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials  GlobeNewswire

Jeito Capital announces significant participation in upsized $207.5 million Series C financing in Aviceda Therapeutics to advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials - GlobeNewswire

Click here to get full coverage on American Vanguard Corporation (AVD): A High-Risk, High-Reward Specialty Chemical Stock - Yahoo Finance

American Vanguard Corporation (AVD): A High-Risk, High-Reward Specialty Chemical Stock  Yahoo Finance

American Vanguard Corporation (AVD): A High-Risk, High-Reward Specialty Chemical Stock - Yahoo Finance

Click here to get full coverage on Nivolumab+AVD Improves Survival in Advanced Classic Hodgkin’s Lymphoma Compared to Brentuximab Vedotin+AVD - 2 Minute Medicine

Nivolumab+AVD Improves Survival in Advanced Classic Hodgkin’s Lymphoma Compared to Brentuximab Vedotin+AVD  2 Minute Medicine

Nivolumab+AVD Improves Survival in Advanced Classic Hodgkin’s Lymphoma Compared to Brentuximab Vedotin+AVD - 2 Minute Medicine

Click here to get full coverage on Nivolumab Regimen Boosts Outcomes in Advanced Hodgkin Lymphoma - Oncology Nursing News

Nivolumab Regimen Boosts Outcomes in Advanced Hodgkin Lymphoma  Oncology Nursing News

Nivolumab Regimen Boosts Outcomes in Advanced Hodgkin Lymphoma - Oncology Nursing News

Click here to get full coverage on Progression-Free Survival Improved With Nivolumab + AVD in Hodgkin Lymphoma - HealthDay

Progression-Free Survival Improved With Nivolumab + AVD in Hodgkin Lymphoma  HealthDay

Progression-Free Survival Improved With Nivolumab + AVD in Hodgkin Lymphoma - HealthDay

Click here to get full coverage on Microsoft warns Azure Virtual Desktop users of black screen issues - BleepingComputer

Microsoft warns Azure Virtual Desktop users of black screen issues  BleepingComputer

Microsoft warns Azure Virtual Desktop users of black screen issues - BleepingComputer

Click here to get full coverage on Is American Vanguard Corporation (NYSE:AVD) Potentially Undervalued? - simplywall.st

Is American Vanguard Corporation (NYSE:AVD) Potentially Undervalued?  simplywall.st

Is American Vanguard Corporation (NYSE:AVD) Potentially Undervalued? - simplywall.st

Click here to get full coverage on VIDEO: AVD-104 shows encouraging results in phase 2/3 study - Healio

VIDEO: AVD-104 shows encouraging results in phase 2/3 study  Healio

VIDEO: AVD-104 shows encouraging results in phase 2/3 study - Healio

Click here to get full coverage on Why Is American Vanguard (AVD) Stock Down 28% Today? - InvestorPlace

Why Is American Vanguard (AVD) Stock Down 28% Today?  InvestorPlace

Why Is American Vanguard (AVD) Stock Down 28% Today? - InvestorPlace

Click here to get full coverage on ArcGIS Pro in Azure Virtual Desktop with Azure Accelerator - Esri

ArcGIS Pro in Azure Virtual Desktop with Azure Accelerator  Esri

ArcGIS Pro in Azure Virtual Desktop with Azure Accelerator - Esri

Click here to get full coverage on American Vanguard: Can New Leadership And Restructuring Reinvigorate The Business? (AVD) - Seeking Alpha

American Vanguard: Can New Leadership And Restructuring Reinvigorate The Business? (AVD)  Seeking Alpha

American Vanguard: Can New Leadership And Restructuring Reinvigorate The Business? (AVD) - Seeking Alpha

Click here to get full coverage on ASRS 2024: Results from part 1 of the Phase 2/3 SIGLEC trial assessing AVD-104 for GA - Ophthalmology Times

ASRS 2024: Results from part 1 of the Phase 2/3 SIGLEC trial assessing AVD-104 for GA  Ophthalmology Times

ASRS 2024: Results from part 1 of the Phase 2/3 SIGLEC trial assessing AVD-104 for GA - Ophthalmology Times

Click here to get full coverage on Nivolumab Plus Chemotherapy Enhances Responses, Is Well Tolerated in Hodgkin Lymphoma - Cancer Network

Nivolumab Plus Chemotherapy Enhances Responses, Is Well Tolerated in Hodgkin Lymphoma  Cancer Network

Nivolumab Plus Chemotherapy Enhances Responses, Is Well Tolerated in Hodgkin Lymphoma - Cancer Network

Click here to get full coverage on Microsoft Confirms New Black Screen Issue Affecting Windows 10 Azure Virtual Desktop Users - Petri IT Knowledgebase

Microsoft Confirms New Black Screen Issue Affecting Windows 10 Azure Virtual Desktop Users  Petri IT Knowledgebase

Microsoft Confirms New Black Screen Issue Affecting Windows 10 Azure Virtual Desktop Users - Petri IT Knowledgebase

Click here to get full coverage on Immunotherapy Plus Chemotherapy: A New Standard of Care for First-Line, Advanced Hodgkin Lymphoma - Inside Precision Medicine

Immunotherapy Plus Chemotherapy: A New Standard of Care for First-Line, Advanced Hodgkin Lymphoma  Inside Precision Medicine

Immunotherapy Plus Chemotherapy: A New Standard of Care for First-Line, Advanced Hodgkin Lymphoma - Inside Precision Medicine

Click here to get full coverage on Mark Your Calendar: American Vanguard Q4 Earnings Coming March 14 - Here's How to Listen In - Stock Titan

Mark Your Calendar: American Vanguard Q4 Earnings Coming March 14 - Here's How to Listen In  Stock Titan

Mark Your Calendar: American Vanguard Q4 Earnings Coming March 14 - Here's How to Listen In - Stock Titan

Click here to get full coverage on Nerdio unleashes latest version of its Microsoft MSP management platform - IT Europa

Nerdio unleashes latest version of its Microsoft MSP management platform  IT Europa

Nerdio unleashes latest version of its Microsoft MSP management platform - IT Europa

Click here to get full coverage on Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma - MedPage Today

Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma  MedPage Today

Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma - MedPage Today

Click here to get full coverage on Army’s new virtual desktop meant real-world problems for some Guard, Reserve users - Breaking Defense

Army’s new virtual desktop meant real-world problems for some Guard, Reserve users  Breaking Defense

Army’s new virtual desktop meant real-world problems for some Guard, Reserve users - Breaking Defense

Click here to get full coverage on American Vanguard Corporation (NYSE:AVD) is largely controlled by institutional shareholders who own 74% of the company - Yahoo Finance

American Vanguard Corporation (NYSE:AVD) is largely controlled by institutional shareholders who own 74% of the company  Yahoo Finance

American Vanguard Corporation (NYSE:AVD) is largely controlled by institutional shareholders who own 74% of the company - Yahoo Finance

Click here to get full coverage on NComputing RX540 Raspberry Pi CM5-powered thin client supports Citrix, Microsoft AVD, WIndows 365, RDS, and more - CNX Software

NComputing RX540 Raspberry Pi CM5-powered thin client supports Citrix, Microsoft AVD, WIndows 365, RDS, and more  CNX Software

NComputing RX540 Raspberry Pi CM5-powered thin client supports Citrix, Microsoft AVD, WIndows 365, RDS, and more - CNX Software

Click here to get full coverage on Nerdio IT Management Chicago, Illinois - The Software Report

Nerdio IT Management Chicago, Illinois  The Software Report

Nerdio IT Management Chicago, Illinois - The Software Report

Click here to get full coverage on Azure Virtual Desktop May Experience 30 mins Black Screen During Logon - CybersecurityNews

Azure Virtual Desktop May Experience 30 mins Black Screen During Logon  CybersecurityNews

Azure Virtual Desktop May Experience 30 mins Black Screen During Logon - CybersecurityNews

Click here to get full coverage on (AVD) Investment Analysis and Advice - news.stocktradersdaily.com

(AVD) Investment Analysis and Advice  news.stocktradersdaily.com

American Vanguard Corporation (AVD)

Price Chart

Key Statistics

Technicals

About AVD

Latest News

Nerdio Manager for MSP 6.0 Brings Unified Microsoft 365 and AVD Management to the Forefront - ChannelE2E

How to set up and use Azure Virtual Desktop - TechTarget

(AVD) Investment Analysis - news.stocktradersdaily.com

Advanced Charts

Top Gainers

Top Losers